Adhesion of thrombotic components to the surface of a clinically used oxygenator is not affected by Trillium coating

Perfusion

Volumn 21, Issue 3, 2006, Pages 165-172

  van den Goor, Jeanette M ^a   van Oeveren, Willem ^b   Rutten, Peter M ^a   Tijssen, Jan G ^a   Eijsman, León ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blood compatibility; Cell adhesion; Extracorporeal circulation; Fibrin; Polycarbonate; Surface modification

Indexed keywords

BLOOD CLOTTING FACTOR 12A; CD11B ANTIGEN; DIMETICONE; FIBRIN; FIBRINOGEN RECEPTOR; POLYMER; THROMBOCYTE RECEPTOR;

ADULT; AGED; ANESTHESIA INDUCTION; ANTIGEN BINDING; ARTICLE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; ELECTIVE SURGERY; HEPARINIZATION; HISTOPATHOLOGY; HUMAN; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; MALE; MATERIAL COATING; OXYGENATOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; VALIDATION PROCESS; VENOUS BLOOD;

AGED; BLOOD PLATELETS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY BYPASS; FACTOR XIIA; FEMALE; FIBRIN; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; OXYGENATORS; PLATELET ADHESIVENESS; PLATELET COUNT; SURFACE PROPERTIES; SURGICAL PROCEDURES, ELECTIVE;

EID: 33745294735     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659106pf859oa     Document Type: Article

References (24)

1. Jansen PG, te Velthuis H, Bulder ER et al. Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 544-49.
2. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
3. Utley JR, Wachtel C, Cain RB, Spaw EA, Collins JC, Stephens DB. Effects of hypothermia, hemodilution, and pump oxygenation on organ water content, blood flow and oxygen delivery, and renal function. Ann Thorac Surg 1981; 31: 121-33.
4. Mahoney CB. Heparin-bonded circuits: clinical outcomes and costs. Perfusion 1998; 13: 192-204.
5. Stammers AH, Christensen KA, Lynch J, Zavadil DP, Deptula JJ, Sydzyik RT. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass. J Extra Corpor Technol 1999; 31: 135-41.
6. Ito Y, Iguchi Y, Kashiwagi T, Imanishi Y. Synthesis and nonthrombogenicity of polyetherurethaneurea film grafted with poly(sodium vinyl sulfonate). J Biomed Mater Res 1991; 25: 1347-61.
7. Silver JH, Hart AP, Williams EC et al. Anticoagulant effects of sulphonated polyurethanes. Biomaterials 1992; 13: 339-44.
8. Lee JH, Kopecek J, Andrade JD. Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. J Biomed Mater Res 1989; 23: 351-68.
9. Mueller XM, Tevaearai HT, Jegger D et al. Antithrombotic properties of trillium coated connectors. ASAIO J 2002; 48: 483-86.
10. Tevaearai HT, Mueller XM, Seigneul I et al. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility. Int J Artif Organs 1999; 22: 629-34.
11. van den Goor JM, Nieuwland R, van den Brink A et al. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response. Eur J Cardiothorac Surg 2004; 26: 926-31.
12. van den Goor JM, van den Brink A, Nieuwland R et al. Generation of platelet-derived microparticles in patients undergoing cardiac surgery is not affected by complement activation. J Thorac Cardiovasc Surg 2003; 126: 1101-106.
13. Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Anesthesiology 1995; 83: 679-89.
14. Spijker HT, Bos R, Busscher HJ, van Kooten T, van Oeveren W. Platelet adhesion and activation on a shielded plasma gradient prepared on polyethylene. Biomaterials 2002; 23: 757-66.
15. Amoroso G, van Boven AJ, Volkers C, Crijns HJ, van Oeveren W. Multilink stent promotes less platelet and leukocyte adhesion than a traditional stainless steel stent: an in vitro experimental study. J Investig Med 2001; 49: 265-72.
16. Oeveren van W. Polyethylene and silicon carbide coated steel promote less complement activation and platelet or leukocyte adhesion than medical steel and silicone rubber material. Prog Biomed Res 2001; 6: 195-201.
17. Belanger MC, Marois Y. Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review. J Biomed Mater Res 2001; 58: 467-77.
18. Ereth MH, Nuttall GA, Clarke SH et al. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass. J Cardiothorac Vas Anesth 2001; 15: 545-50.
19. Palanzo DA, Zarro DL, Montesano RM et al. Effect of Trillium Biopassive Surface coating of the oxygenator on platelet count drop during cardiopulmonary bypass. Perfusion 1999; 14: 473-79.
20. Maquelin KN, Berckmans RJ, Nieuwland R et al. Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998; 115: 1160-65.
21. Aldea GS, Soltow LO, Chandler WL et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002; 123: 742-55.
22. De Somer F, Van Belleghem Y, Caes F et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002; 123: 951-58.
23. de Haan J, Boonstra PW, Tabuchi N, van Oeveren W, Ebels T. Retransfusion of thoracic wound blood during heart surgery obscures biocompatibility of the extracorporeal circuit. J Thorac Cardiovasc Surg 1996; 111: 272-75.
24. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH Jr. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 97: 235-39